Ftse Mib
38.767,75
0,77%
DAX
22.467,18
0,20%
S&P 500
5.983,25
0,00%
NASDAQ
19.286,92
0,00%
Bitcoin
88.997,39
-2,67%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Qiagen NV (QGEN) Qiagen NV (QGEN) Notizie

Qiagen NV

QGEN
40,12
0,21 (0,53%)
Pre Mercato
Ultimo aggiornamento: 14:16:51
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/2/202522:05BWQIAGEN Strengthens Global Bioinformatics Leadership With New..
05/2/202522:05BWQIAGEN übertrifft Prognose für viertes Quartal 2024 mit..
04/2/202522:05BWQIAGEN receives positive court decision reaffirming an..
16/1/202523:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202522:05BWQIAGEN gibt Details zum Abschluss des synthetischen..
15/1/202514:13BWQIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
13/1/202521:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202519:05BWQIAGEN to Return Approximately $300 Million to Shareholders..
10/1/202507:30BWTiefere Erkenntnisse aus biologischen Proben: QIAGEN..
09/1/202522:05BWQIAGEN erhält U.S.-Zulassung für erstes QIAstat-Dx..
07/1/202522:05BWQIAGEN Supports UK Initiative to Sequence Genomes of 100,000..
12/12/202422:05BWQIAGEN führt KI-Erweiterung für Ingenuity Pathway Analysis..
05/12/202422:05BWQIAGEN Reaches Milestone With Over 1,000 Placements of EZ2..
28/11/202412:00BWQIAGEN stärkt QIAstat-Dx mit neuem Standort in Barcelona zur..
27/11/202422:05GLOBEQIAGEN launches novel tools for customizing digital PCR..
12/11/202422:05GLOBEQIAGEN collaborates with McGill University to advance..
07/11/202417:46EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
06/11/202422:05GLOBEQIAGEN delivers solid Q3 2024 growth ahead of outlook,..
04/11/202407:30GLOBEQIAGEN receives FDA clearance of QIAstat-Dx..
29/10/202407:30GLOBEQIAGEN receives FDA clearance for QIAstat-Dx mini panel to..
10/10/202422:05GLOBEQIAGEN expands automated liquid biopsy portfolio to enhance..
10/10/202413:41GLOBEQIAGEN N.V. to release results for Q3 2024 and hold webcast
07/10/202422:05GLOBEGlobal TB Summit 2024: QIAGEN leads the charge as..
30/9/202422:05GLOBEQIAGEN launches QIAcuityDx digital PCR system for clinical..
26/9/202422:05GLOBEQIAGEN receives European IVDR certification for QIAstat-Dx..
25/9/202422:05GLOBEPreAnalytiX, a QIAGEN and BD joint venture, launches novel..
23/9/202422:05GLOBEQIAGEN and Bode Technology partner to advance use of..
18/9/202422:05GLOBEQIAGEN expands QIAcuity digital PCR offering with over new..
12/9/202422:05GLOBEQIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance..
12/9/202400:18EDGAR2Form 144 - Report of proposed sale of securities
04/9/202422:05GLOBEQIAGEN and Lilly collaborate to support development of a..
03/9/202422:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202422:05GLOBEQIAGEN expands QIAstat-Dx into precision medicine through..
06/8/202422:05GLOBEMyriad Genetics Reports Strong Second Quarter 2024 Financial..
02/8/202403:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/7/202422:06GLOBEQIAGEN delivers solid performance and exceeds outlook for Q2..
08/7/202422:05GLOBEQIAGEN to enhance the identification of human remains of..
02/7/202415:29GLOBEQIAGEN N.V. to release results for Q2 2024 and hold webcast
27/6/202422:05GLOBEQIAGEN welcomes new U.S. guidelines for use of..
17/6/202413:30GLOBEQIAGEN announces 2028 strategy for solid profitable growth
13/6/202422:05GLOBEQIAGEN’s software QCI Interpret accelerates clinical..
12/6/202422:05GLOBEQIAGEN publishes 2023 sustainability report, highlighting..
11/6/202422:05GLOBEQIAGEN launches new QIAcuity digital PCR assays for..
06/6/202422:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202422:05GLOBEQIAGEN to discontinue NeuMoDx integrated PCR testing system,..
05/6/202422:05GLOBEQIAGEN launches digital PCR Assay Design Tool for QIAcuity,..
03/6/202408:00GLOBEQIAGEN expands QIAstat-Dx syndromic testing menu in the U.S...
31/5/202422:42EDGAR2Form SD - Specialized disclosure report
30/5/202423:55GLOBEQIAGEN and Myriad Genetics develop distributable homologous..
30/5/202422:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: Min: Max:
Chiusura: 39,91

La tua Cronologia

NYSE
QGEN
Qiagen NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci